The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

Also called NCT06503016

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose supportive care
Phase
Phase 3
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Università Vita-Salute San Raffaele (from the registry)
Registry
  • NCT NCT06503016
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06503016. Randomized; double masking; primary purpose supportive care. Start 2024-10-08 (actual); primary completion 2026-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients
Acronym
SPHERE
Condition
Hypotension
Condition
Consciousness, Level Altered
Condition
Airway Disease
Condition
Respiratory Failure
Condition
Tachypnea
Condition
Bradypnea
Condition
Tachycardia
Condition
Bradycardia
Condition
Cardiac Failure
Intervention (Drug)
Phosphocreatine
Intervention (Drug)
Placebo
Lead sponsor
Università Vita-Salute San Raffaele (class: other)
Collaborator
Silvia Ajello (class: not stated)

Record details

Record id
cardio:ct-nct06503016
Content hash
797b1940e34885518692b3cb5c8a7bd531faa02a6d1ab3a44a247242ddda877d